Entrepreneurship AND Innovation for Leber's Congenital Amaurosis E AND ILCA)

About Entrepreneurship AND Innovation for Leber's Congenital Amaurosis E AND ILCA)

Entrepreneurship & Innovation for Leber’s Congenital Amaurosis (E&ILCA) started in January’16. E&ILCA is a for-purpose enterprise focused on improving family life for those suffering from LCA. E&ILCA's main focus is cutting-edge technologies, advancing translational sciences & global liaising for genetically caused blindness. To integrate patient-centric research with scientific expertise, E&ILCA leads in the proactive establishment of communication between global stakeholders. With the use of numerous social media platforms, virtual conferences, local scientific events, national symposium and international conferences, E&ILCA raises public awareness & educates about the needs of rare disease patients. E&ILCA successfully created and implemented unconventional and innovative ways to engage the general public.

Keywords

• Biotechnology
• Oligonucleotides
• Rare Diseases
• Start-Up

Address

• Headquarters

  LeidenZuid-Holland, Netherlands